ATE427947T1 - Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren - Google Patents
Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitorenInfo
- Publication number
- ATE427947T1 ATE427947T1 AT03757806T AT03757806T ATE427947T1 AT E427947 T1 ATE427947 T1 AT E427947T1 AT 03757806 T AT03757806 T AT 03757806T AT 03757806 T AT03757806 T AT 03757806T AT E427947 T1 ATE427947 T1 AT E427947T1
- Authority
- AT
- Austria
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- receptor tyrosine
- heterocyclic substituted
- substituted indolinones
- Prior art date
Links
- 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2002142350 DE10242350A1 (de) | 2002-09-12 | 2002-09-12 | Heterocyclisch substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE10252969A DE10252969A1 (de) | 2002-11-14 | 2002-11-14 | Heterocyclisch substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE427947T1 true ATE427947T1 (de) | 2009-04-15 |
Family
ID=32031471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03757806T ATE427947T1 (de) | 2002-09-12 | 2003-09-09 | Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7148249B2 (https=) |
| EP (1) | EP1551830B1 (https=) |
| JP (1) | JP2006501273A (https=) |
| AR (1) | AR041194A1 (https=) |
| AT (1) | ATE427947T1 (https=) |
| AU (1) | AU2003273842A1 (https=) |
| CA (1) | CA2498781A1 (https=) |
| DE (1) | DE50311397D1 (https=) |
| ES (1) | ES2324710T3 (https=) |
| PE (1) | PE20041080A1 (https=) |
| TW (1) | TW200407125A (https=) |
| WO (1) | WO2004026829A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6982260B1 (en) | 1999-11-22 | 2006-01-03 | Warner-Lambert Company | Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
| DE60144284D1 (de) | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
| US20040204458A1 (en) * | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
| UA83881C2 (en) | 2003-12-18 | 2008-08-26 | Янссен Фармацевтика Н.В. | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| KR100629713B1 (ko) * | 2004-04-10 | 2006-09-29 | (주)아모레퍼시픽 | 펜타에리스리톨 유도체와 이의 제조방법, 및 이를포함하는 액정베이스 |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| CA2654583C (en) | 2006-07-13 | 2015-11-24 | Janssen Pharmaceutica N.V. | Mtki quinazoline derivatives |
| CA2663147A1 (en) * | 2006-09-11 | 2008-03-20 | Curis, Inc. | Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| CA2687909C (en) * | 2007-06-21 | 2015-09-15 | Janssen Pharmaceutica Nv | Indolin-2-ones and aza-indolin-2-ones |
| ES2562218T3 (es) | 2007-07-27 | 2016-03-03 | Janssen Pharmaceutica, N.V. | Pirrolopirimidinas útiles para el tratamiento de enfermedades proliferativas |
| BRPI0820689A2 (pt) * | 2007-12-03 | 2019-09-24 | Boehringer Ingelheim Int | processo de produção de um derivado de indolinona |
| UY31506A1 (es) * | 2007-12-03 | 2009-08-03 | Derivados de indolinona y procedimiento para su preparacion | |
| EP2235004A4 (en) * | 2007-12-21 | 2011-05-04 | Univ Health Network | INDAZOLYL, BENZIMIDAZOLYL, BENZOTRIAZOLYL-SUBSTITUTED INDOLUND DERIVATIVES AS A KINASE-HEMMER FOR CANCER TREATMENT |
| PT2293795E (pt) * | 2008-06-06 | 2015-11-17 | Boehringer Ingelheim Int | Combinação farmacêutica |
| NZ590560A (en) | 2008-07-29 | 2012-12-21 | Boehringer Ingelheim Int | Indolinone Inhibitors of cell cycle kinases |
| JP5629752B2 (ja) * | 2009-04-06 | 2014-11-26 | ユニバーシティ・ヘルス・ネットワークＵｎｉｖｅｒｓｉｔｙ Ｈｅａｌｔｈ Ｎｅｔｗｏｒｋ | キナーゼインヒビターおよびこれを用いた癌の治療方法 |
| JP5442906B2 (ja) * | 2010-04-06 | 2014-03-19 | ユニバーシティ・ヘルス・ネットワーク | キナーゼインヒビターおよびこれを用いた癌の治療方法 |
| WO2012048411A1 (en) * | 2010-10-13 | 2012-04-19 | University Health Network | Plk-4 inhibitors and method of treating cancer with same |
| CN103848814B (zh) * | 2012-12-06 | 2016-08-17 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的取代吲哚满酮衍生物 |
| DK2930167T3 (en) | 2012-12-06 | 2019-02-25 | Kbp Biosciences Co Ltd | INDOLINO DERIVATIVE AS A TYROSINKINASE INHIBITOR |
| EP3012248B1 (en) | 2013-06-20 | 2019-09-11 | Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China | Substance having tyrosine kinase inhibitory activity and preparation method and use thereof |
| SG11201602882VA (en) | 2013-10-18 | 2016-05-30 | Univ Health Network | Treatment for pancreatic cancer |
| WO2018124001A1 (ja) | 2016-12-27 | 2018-07-05 | 国立研究開発法人理化学研究所 | Ｂｍｐシグナル阻害化合物 |
| CN112174943A (zh) * | 2019-07-03 | 2021-01-05 | 四川大学 | 一种吲哚-2-酮类化合物在制备防治口腔细菌产品中的用途 |
| CN114213396B (zh) * | 2022-01-27 | 2023-03-24 | 深圳市乐土生物医药有限公司 | 一种吲哚-2-酮类化合物及其制备方法与用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1115704E (pt) * | 1998-09-25 | 2003-11-28 | Boehringer Ingelheim Pharma | Novas indolinonas substituidas com accao inibidora sobre varias quinases e complexos ciclina/cdk |
| CA2381821A1 (en) | 1999-08-27 | 2001-03-08 | Boehringer Ingelheim Pharma Kg | Substituted indolinones, their manufacture and their use as medicaments |
| DE19949209A1 (de) | 1999-10-13 | 2001-04-19 | Boehringer Ingelheim Pharma | In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6762180B1 (en) * | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
| UA75054C2 (uk) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
| DE10117204A1 (de) * | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
-
2003
- 2003-09-05 US US10/656,863 patent/US7148249B2/en not_active Expired - Lifetime
- 2003-09-09 DE DE50311397T patent/DE50311397D1/de not_active Expired - Lifetime
- 2003-09-09 JP JP2004537020A patent/JP2006501273A/ja active Pending
- 2003-09-09 EP EP03757806A patent/EP1551830B1/de not_active Expired - Lifetime
- 2003-09-09 AT AT03757806T patent/ATE427947T1/de not_active IP Right Cessation
- 2003-09-09 AU AU2003273842A patent/AU2003273842A1/en not_active Abandoned
- 2003-09-09 CA CA002498781A patent/CA2498781A1/en not_active Abandoned
- 2003-09-09 WO PCT/EP2003/009978 patent/WO2004026829A2/de not_active Ceased
- 2003-09-09 ES ES03757806T patent/ES2324710T3/es not_active Expired - Lifetime
- 2003-09-10 PE PE2003000915A patent/PE20041080A1/es not_active Application Discontinuation
- 2003-09-10 TW TW092125060A patent/TW200407125A/zh unknown
- 2003-09-12 AR ARP030103306A patent/AR041194A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1551830A2 (de) | 2005-07-13 |
| US20050054710A1 (en) | 2005-03-10 |
| TW200407125A (en) | 2004-05-16 |
| JP2006501273A (ja) | 2006-01-12 |
| DE50311397D1 (de) | 2009-05-20 |
| WO2004026829A2 (de) | 2004-04-01 |
| CA2498781A1 (en) | 2004-04-01 |
| AU2003273842A8 (en) | 2004-04-08 |
| WO2004026829A3 (de) | 2004-10-07 |
| EP1551830B1 (de) | 2009-04-08 |
| PE20041080A1 (es) | 2005-02-17 |
| AR041194A1 (es) | 2005-05-04 |
| ES2324710T3 (es) | 2009-08-13 |
| AU2003273842A1 (en) | 2004-04-08 |
| US7148249B2 (en) | 2006-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE427947T1 (de) | Heterocyclisch substituierte indolinone und deren verwendung als rezeptor-tyrosinkinasen inhibitoren | |
| DE60325761D1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
| ATE430754T1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
| DE60121595D1 (de) | Mannich base prodrugs von 3-(pyrrol-2-ylmethylidene)-2-indolinon derivate und deren verwendung als protein kinase inhibitoren | |
| ATE316527T1 (de) | Substituierte indolinone als tyrosinkinase inhibitoren | |
| ATE280757T1 (de) | Indolderivate und ihre verwendung als mcp-1 rezeptor antagonisten | |
| DE602005016162D1 (de) | Benzimidazolderivate und ihre Verwendung als AII Rezeptor-Antagonist | |
| DE602005023639D1 (de) | Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten | |
| DE60221233D1 (de) | Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren | |
| ATE394102T1 (de) | Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren | |
| DK2233483T3 (da) | Indol- eller benzimidazol-derivater til modulering af IKB-kinase og mellemprodukter til fremstilling deraf | |
| DE60324767D1 (de) | Fluoro substituierte cycloalkanindole und deren verwendung als prostaglandin d2 rezeptor antagonisten | |
| ATE400569T1 (de) | 4-substituierte 1-aminocyclohexan-derivate zur verwendung als orl1-rezeptor- und mu-opiat- rezeptor-liganden | |
| ATE395346T1 (de) | Chinazolinderivate als tyrosinkinaseinhibitoren | |
| ATE293620T1 (de) | Indol-3-yl-derivate und deren verwendung als integrin-inhibitoren | |
| DE60336266D1 (de) | Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl-piperazinderivate und deren verwendung als neurokinin antagonisten | |
| ATE551329T1 (de) | Chinazolinonderivate und deren verwendung als cb- agonisten | |
| DE602005006567D1 (de) | Indolderivate als histaminrezeptorantagonisten | |
| DE602004022458D1 (de) | Pyrazolderivate und ihre verwendung als orexin-rezeptor-antagonisten | |
| DE602005025110D1 (de) | Heterocyclische verbindungen und deren verwendung als aldosteronsynthaseinhibitoren | |
| ATE399768T1 (de) | Indazolderivate und ihre verwendung als crf antagonisten | |
| DE60320457D1 (de) | Tetrahydrochinolinderivate und deren verwendung als modulatoren des fsh rezeptors | |
| ATE402923T1 (de) | 2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren | |
| ATE538130T1 (de) | Pyrimidinderivate und ihre verwendung als p2y12- rezeptorantagonisten | |
| ATE396185T1 (de) | Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |